Search results for "dron"

showing 10 items of 4363 documents

Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid

2016

Background Bisphosphonates have a high adsorption on calcified tissues and are commonly used in the treatment of bone disorder diseases. Conjugates of bisphosphonates with macrocyclic chelators open new possibilities in bone targeted radionuclide imaging and therapy. Subsequent to positron emission tomography (PET) examinations utilizing 68Ga-labelled analogues, endoradiotheraphy with 177Lu-labelled macrocyclic bisphosphonates may have a great potential in the treatment of painful skeletal metastases. Methods Based on the established pharmaceuticals pamidronate and zoledronate two new DOTA-α-OH-bisphosphonates, DOTAPAM and DOTAZOL(MM1.MZ) were successfully synthesized. The ligands were labe…

lcsh:Medical physics. Medical radiology. Nuclear medicineBiodistributionMaterials sciencelcsh:R895-920Hydroxy bisphosphonatesSingle-photon emission computed tomography01 natural sciences030218 nuclear medicine & medical imagingAnalytical Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsmedicineDOTAPharmacology (medical)Radiology Nuclear Medicine and imagingZoledronic acidPharmacologymedicine.diagnostic_test010405 organic chemistrybusiness.industryResearchBone metastaseslcsh:RM1-950Pamidronic acid177LuTheranostics68Ga0104 chemical sciencesZoledronic acidPETlcsh:Therapeutics. PharmacologyDOTAchemistryPositron emission tomographyNuclear medicinebusinessEx vivomedicine.drugEJNMMI Radiopharmacy and Chemistry
researchProduct

Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging

2019

Background Pretargeted imaging allows the use of short-lived radionuclides when imaging the accumulation of slow clearing targeting agents such as antibodies. The biotin-(strept)avidin and the bispecific antibody-hapten interactions have been applied in clinical pretargeting studies; unfortunately, these systems led to immunogenic responses in patients. The inverse electron demand Diels-Alder (IEDDA) reaction between a radiolabelled tetrazine (Tz) and a trans-cyclooctene (TCO)-functionalized targeting vector is a promising alternative for clinical pretargeted imaging due to its fast reaction kinetics. This strategy was first applied in nuclear medicine using an 111In-labelled Tz to image TC…

lcsh:Medical physics. Medical radiology. Nuclear medicineBiodistributionlcsh:R895-920Tetrazine010402 general chemistry01 natural sciencesChemical kineticsTetrazinechemistry.chemical_compoundMedicineDOTARadiology Nuclear Medicine and imagingPretargeted imagingInverse electron-demand Diels–Alder reactionAlendronic acidOriginal ResearchPretargetingTrans-cyclooctene (TCO)biologymedicine.diagnostic_test010405 organic chemistrybusiness.industryScandium-44 (44Sc)RadiochemistryBisphosphonates0104 chemical sciences3. Good healthchemistryPositron emission tomographyPositron emission tomography (PET)biology.proteinInverse electron demand Diels-Alder (IEDDA)businessAvidinEJNMMI Research
researchProduct

A fast and simple spectrofluorometric method for the determination of alendronate sodium in pharmaceuticals

2014

Introduction: Alendronate sodium enhances bone formation and increases osteoblast proliferation and maturation and leads to the inhibition of osteoblast apoptosis. Therefore, a rapid and simple spectrofluorometric method has been developed and validated for the quantitative determination of it. Methods: The procedure is based on the reaction of primary amino group of alendronate with o-phthalaldehyde (OPA) in sodium hydroxide solution. Results: The calibration graph was linear over the concentration range of 0.0-2.4 μM and limit of detection and limit of quantification of the method was 8.89 and 29 nanomolar, respectively. The enthalpy and entropy of the reaction between alendronate sodium …

lcsh:R5-920AlendronateEnthalpylcsh:Biology (General)Entropy610 Medical sciences; MedicineSpectrofluorimetryO-phthalaldehydelcsh:Medicine (General)lcsh:QH301-705.5Research ArticleBioImpacts
researchProduct

Bathymetry time series using high spatial resolution satellite images

2020

The use of the new generation of remote sensors, such as echo sounders and Global Navigation Satellite System (GNSS) receivers with differential correction installed in a drone, allows the acquisition of high-precision data in areas of shallow water, as in the case of the channel of the Encañizadas in the Mar Menor lagoon. This high precision information is the first step to develop the methodology to monitor the bathymetry of the Mar Menor channels. The use of high spatial resolution satellite images is the solution for monitoring many hydrological changes and it is the basis of the three-dimensional (3D) numerical models used to study transport over time, environmental variability, and wa…

lcsh:TD201-5003305.15 Ingeniería Hidráulicalcsh:Hydraulic engineeringGeography Planning and DevelopmentEcho (computing)Mar MenorSpatio-temporal variabilitySatellite systemspatio-temporal variabilityAquatic ScienceBiochemistryDroneWaves and shallow waterlcsh:Water supply for domestic and industrial purposesGNSS applicationslcsh:TC1-978Pleiades-1SatelliteBathymetryIngeniería HidráulicaImatges tridimensionals en biologiaGeologyWater Science and TechnologyRemote sensingCommunication channel
researchProduct

Searches for lepton number violation and resonances in K± → πμμ decays

2017

The NA48/2 experiment at CERN collected a large sample of charged kaon decays to final states with multiple charged particles in 2003–2004. A new upper limit on the rate of the lepton number violating decay K±→π∓μ±μ± is reported: B(K±→π∓μ±μ±)<8.6×10−11 at 90% CL. Searches for two-body resonances X in K±→πμμ decays (such as heavy neutral leptons N4 and inflatons χ ) are also presented. In the absence of signals, upper limits are set on the products of branching fractions B(K±→μ±N4)B(N4→πμ) and B(K±→π±X)B(X→μ+μ−) for ranges of assumed resonance masses and lifetimes. The limits are in the (10−11,10−9) range for resonance lifetimes below 100 ps.

leptonBEAM01 natural sciences7. Clean energyPhysics Particles & FieldsHigh Energy Physics - ExperimentLIMITSkaon physicsCERNIntermediate statelepton number violation neutrinos dark matter kaon physicsPhysicsVMSMLarge Hadron ColliderPhysicsCharge KaonsneutrinosNuclear and High Energy Physics; CERN; leptonsHigh Energy Physics - Experiment; Charge Kaons; Lepton number violationNuclear & Particles PhysicsCharged particlelcsh:QC1-999NEUTRAL HEAVY-LEPTONSPhysics Nuclearlepton number violationPhysical SciencesParticle physicsNuclear and High Energy Physicsleptonskaon decays lepton number violationNuclear and High Energy Physics lepton kaon meson lepton number violation NA48Socio-culturaleAstronomy & AstrophysicsUPPER-BOUNDSdark matterNuclear physics0202 Atomic Molecular Nuclear Particle And Plasma Physics0103 physical sciencesDARK-MATTERPARTICLES010306 general physicsScience & Technologykaon decays010308 nuclear & particles physicsBranching fractionResonanceInflatonLepton numberkaon mesonNA48High Energy Physics::Experimentlcsh:PhysicsLepton
researchProduct

Lidaparātu trajektoriju konstruēšana balstoties uz Bezjē līknēm

2015

Pēdējos gados ļoti strauji attīstās tāda robotikas nozare, kā visu veidu lidojošie droni: kvadro- kopteri, oktakoperi u.t.t. Tehnoloģiju attīstības dēļ palika reāla autonomo dronu realizācija un sāka parādīties daži veidi, kā izmantot dronus. Darbā tiek izstrādāts autonomā kvadrokoptera trajektorijas konstruēšanas algoritms, balstoties uz Bezjē līknēm. Tiek apskatīts iepriekš izman- totais algoritms, tā trūkumi un priekšrocības. Izstrādātais algoritms tika implementēts Latvijas izstrādātajā dronā ”AirDog” un salīdzināti vecā un jaunā algoritma darbības rezultāti dažādos apstākļos.

lidojošie droniMatemātikalidošanas algoritmiBezjē līkneskvadrokopteri
researchProduct

Rola innowacji w kształtowaniu przepływów towarowych

2016

logistics innovationinnowacje logistycznetransportdrongigalinerdroneZeszyty Naukowe Politechniki Śląskiej. Organizacja i Zarządzanie
researchProduct

STATUS OF STRANGENESS ELECTRO-PRODUCTION AT MAMI

2009

At the Institut für Kernphysik in Mainz, Germany, the microtron MAMI has been upgraded to 1.5 GeV electron beam energy and can now be used to study strange hadronic systems. The magnetic spectrometer KAOS from GSI was dismantled and re-installed in the spectrometer facility operated by the A1 collaboration. The spectrometer's primary purpose is to study strangeness electro-production. Its compact design and its capability to detect negative and positive charged particles simultaneously under forward scattering angles complements the existing spectrometers. In 2008, an important milestone has been reached by the successful measurement of kaon production off a liquid hydrogen target. The ide…

magnetic spectrometer; particle detector design; kaon electro-production; hypernuclei electro-productionPhysicsNuclear and High Energy PhysicsParticle physicsSpectrometerPhysics::Instrumentation and DetectorsScatteringNuclear TheoryHadronDetectorGeneral Physics and AstronomyStrangenessCharged particleNuclear physicsPhysics::Accelerator PhysicsVacuum chamberNuclear ExperimentMicrotronStrangeness in Nuclear and Hadronic Systems
researchProduct

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells

2012

Zoledronic acid (ZOL) is the most potent nitrogen-containing bisphosphonate (N-BPs) that strongly binds to bone mineral and acts as a powerful inhibitor of bone resorption, already clinically available for the treatment of patients with osteolytic metastases. Recent data also suggest that ZOL, used in breast cancer, may provide more than just supportive care modifying the course of the disease, though the possible molecular mechanism of action is still unclear. As breast cancer is one of the primary tumours with high propensity to metastasize to the bone, we investigated, for the first time, differential gene expression profile on Michigan Cancer Foundation-7 (MCF-7) breast cancer cells tre…

medicine.medical_specialtyAngiogenesismedicine.medical_treatmentBlotting WesternAngiogenesis InhibitorsAntineoplastic AgentsBreast NeoplasmsBiologyReal-Time Polymerase Chain ReactionZoledronic AcidZOL FN1 TGF-b1 THBS-1 invasion breast cancerBone resorptionThrombospondin 1Transforming Growth Factor beta1breast cancerBreast cancerTGF-β1Internal medicineThrombospondin 1medicineHumansBone ResorptionCell ProliferationMatrigelDiphosphonatesFN1Gene Expression ProfilingImidazolesCancerOriginal ArticlesCell BiologyZOLBisphosphonateMicroarray Analysisinvasionmedicine.diseaseFibronectinsUp-RegulationGene Expression Regulation NeoplasticEndocrinologyZoledronic acidTHBS-1MCF-7 CellsCancer researchMolecular MedicineFemalemedicine.drug
researchProduct

Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis

2011

Introduction: Bisphosphonates are the first-choice treatment for osteoporosis. They effectively increase bone mineral density, reduce markers of bone resorption, and lower the incidence of new fractures in patients with osteoporosis-related fracture. However, the efficacy observed in clinical trials may not be realized in a real-life setting, partly due to poor adherence to therapy, with a significant worsening of clinical outcomes. Several issues contribute to poor adherence to osteoporosis medication, including inconvenient dosing regimens and concerns about possible adverse events. Although strategies to improve adherence have been investigated, new approaches are required. Areas covered…

medicine.medical_specialtyBone Density Conservation AgentBone densityOsteoporosisAlternative medicineadherence; osteoporosis; treatment algorithm; bone density; medication possession ratio; bisphosphonatesMedication AdherenceClinical ProtocolsCost of IllnessTreatment algorithmmedicineHumansBisphosphonatePharmacology (medical)DosingClinical ProtocolAdverse effectMED/01 - STATISTICA MEDICAOsteoporosis PostmenopausalAdherence bisphosphonates bone density medication possession ratio osteoporosis treatment algorithmMedication possession ratioPharmacologyBone Density Conservation Agentsbusiness.industryOsteoporosiGeneral Medicinemedicine.diseaseAlgorithmCost of IllneClinical trialBone Density Conservation AgentsTreatment OutcomeZoledronic acidAdherenceAdherence; Bisphosphonates; Bone density; Medication possession ratio; Osteoporosis; Treatment algorithm; Algorithms; Bone Density Conservation Agents; Clinical Protocols; Cost of Illness; Female; Humans; Osteoporosis; Osteoporosis Postmenopausal; Treatment Outcome; Medication Adherence; Pharmacology; Pharmacology (medical)Physical therapyOsteoporosisFemaleBone densitybusinessAlgorithmsHumanmedicine.drugExpert Opinion on Pharmacotherapy
researchProduct